Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of Remimazolam on the Incidence of Hypoxia During Sedated Hysteroscopy for Assisted Reproduction in Overweight or Obese Patients: a Randomized, Controlled Clinical Trial

NCT06004843 is registered in ClinicalTrials.gov with RenJi Hospital as lead sponsor.

NCT NCT06004843
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06004843 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of Remimazolam on the Incidence of Hypoxia During Sedated Hysteroscopy for Assisted Reproduction in Overweight or Obese Patients: a Randomized, Controlled Clinical Trial
Lead sponsor
RenJi Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
August 31, 2023
Completion date
April 30, 2026
Enrollment
600 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypoxia, hysteroscopy, overweight or obesity